Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1132610-06-0

C36H42N6O6 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1132610-06-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1132610-06-0 Structure

  • Basic information

    1. Product Name: C36H42N6O6
    2. Synonyms:
    3. CAS NO:1132610-06-0
    4. Molecular Formula:
    5. Molecular Weight: 654.766
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1132610-06-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C36H42N6O6(CAS DataBase Reference)
    10. NIST Chemistry Reference: C36H42N6O6(1132610-06-0)
    11. EPA Substance Registry System: C36H42N6O6(1132610-06-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1132610-06-0(Hazardous Substances Data)

1132610-06-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1132610-06-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,3,2,6,1 and 0 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1132610-06:
(9*1)+(8*1)+(7*3)+(6*2)+(5*6)+(4*1)+(3*0)+(2*0)+(1*6)=90
90 % 10 = 0
So 1132610-06-0 is a valid CAS Registry Number.

1132610-06-0Downstream Products

1132610-06-0Relevant articles and documents

2-(6-Phenyl-1H-indazol-3-yl)-1H-benzo[d]imidazoles: Design and synthesis of a potent and isoform selective PKC-ζ inhibitor

Trujillo, John I.,Kiefer, James R.,Huang, Wei,Thorarensen, Atli,Xing, Li,Caspers, Nicole L.,Day, Jacqueline E.,Mathis, Karl J.,Kretzmer, Kuniko K.,Reitz, Beverley A.,Weinberg, Robin A.,Stegeman, Roderick A.,Wrightstone, Ann,Christine, Lori,Compton, Robert,Li, Xiong

scheme or table, p. 908 - 911 (2009/09/06)

The inhibition of PKC-ζ has been proposed to be a potential drug target for immune and inflammatory diseases. A series of 2-(6-phenyl-1H indazol-3-yl)-1H-benzo[d]imidazoles with initial high crossover to CDK-2 has been optimized to afford potent and selec

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1132610-06-0